Hemolytic-uremic syndrome secondary prevention: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} ==Overview== There are no established measures for the secondary prevention of [disease name]. OR Effective measures for the secondary pr..." |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Hemolytic-uremic syndrome}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
Revision as of 16:53, 17 August 2018
Template:Hemolytic-uremic syndrome Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]